


<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
         xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
    <responseDate>2025-09-09T14:04:35Z</responseDate>
    <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:12406509" metadataPrefix="pmc">https://pmc.ncbi.nlm.nih.gov/api/oai/v1/mh/</request>
    
    <GetRecord>
        <record>
    <header>
    <identifier>oai:pubmedcentral.nih.gov:12406509</identifier>
    <datestamp>2025-09-04</datestamp>
    
        
        <setSpec>perimed</setSpec>
        
    
        
        <setSpec>pmc-open</setSpec>
        
    
</header>
    <metadata>
        
        <article xmlns="https://jats.nlm.nih.gov/ns/archiving/1.4/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.4/ https://jats.nlm.nih.gov/archiving/1.4/xsd/JATS-archivearticle1-4.xsd" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Perioper Med (Lond)</journal-id><journal-id journal-id-type="iso-abbrev">Perioper Med (Lond)</journal-id><journal-id journal-id-type="pmc-domain-id">2293</journal-id><journal-id journal-id-type="pmc-domain">perimed</journal-id><journal-title-group><journal-title>Perioperative Medicine</journal-title></journal-title-group><issn pub-type="epub">2047-0525</issn><publisher><publisher-name>BMC</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12406509</article-id><article-id pub-id-type="pmcid-ver">PMC12406509.1</article-id><article-id pub-id-type="pmcaid">12406509</article-id><article-id pub-id-type="pmcaiid">12406509</article-id><article-id pub-id-type="pmid">40898271</article-id><article-id pub-id-type="doi">10.1186/s13741-025-00579-9</article-id><article-id pub-id-type="publisher-id">579</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Effective doses of alfentanil combined with propofol for gastroscopy in patients of different ages under Narcotrend monitoring: a prospective dose-finding study utilizing the up-and-down sequential allocation method</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Jiang</surname><given-names initials="L">Lili</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Peng</surname><given-names initials="Z">Zhe</given-names></name><xref ref-type="aff" rid="Aff3">3</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Deng</surname><given-names initials="Y">Yuhui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Qin</surname><given-names initials="Z">Zebang</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Li</surname><given-names initials="J">Jianxia</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Huang</surname><given-names initials="J">Jinping</given-names></name><address><email>huangjpsmu@163.com</email></address><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Qin</surname><given-names initials="Z">Zaisheng</given-names></name><address><email>zsqinsmu@163.com</email></address><xref ref-type="aff" rid="Aff1">1</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/01eq10738</institution-id><institution-id institution-id-type="GRID">grid.416466.7</institution-id><institution-id institution-id-type="ISNI">0000 0004 1757 959X</institution-id><institution>Nanfang Hospital, Southern Medical University, </institution></institution-wrap>Guangzhou, China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/0050r1b65</institution-id><institution-id institution-id-type="GRID">grid.413107.0</institution-id><institution>The Seventh Affiliated Hospital of Southern Medical University, </institution></institution-wrap>Foshan, China </aff><aff id="Aff3"><label>3</label>Foshan Maternity and Children&#8217;s Hospital, Foshan, China </aff></contrib-group><pub-date pub-type="epub"><day>2</day><month>9</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>14</volume><issue-id pub-id-type="pmc-issue-id">478634</issue-id><elocation-id>94</elocation-id><history><date date-type="received"><day>14</day><month>11</month><year>2024</year></date><date date-type="accepted"><day>11</day><month>8</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>02</day><month>09</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>04</day><month>09</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-09-04 10:25:45.023"><day>04</day><month>09</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri content-type="pmc-pdf" xlink:href="13741_2025_Article_579.pdf"/><abstract id="Abs1"><sec><title>Background</title><p id="Par7">Painless gastroscopy is preferred by both patients and physicians, as it minimizes discomfort during the procedure. Alfentanil, a short-acting opioid analgesic, possesses pharmacological properties that make it suitable for inducing analgesia during gastroscopy. However, research on the optimal dosage of alfentanil when used in combination with propofol for gastroscopy is limited. Therefore, this study aimed to investigate the 50% and 95% effective doses (ED50 and ED95, respectively) of alfentanil in combination with propofol for gastroscopy, using Narcotrend monitoring.</p></sec><sec><title>Methods</title><p id="Par8">Elective gastroscopy was performed in 51 patients aged 18&#8211;80 years, with a body mass index of 18&#8211;28 kg/m<sup>2</sup>, and American Society of Anesthesiologists Class I or II. Based on their age, they were categorized into the youth group (18&#8211;60 years) and the elderly group (61&#8211;80 years). The patients were connected to the vital signs monitor and Narcotrend, and propofol was administered intravenously until the Narcotrend index was at Stage C1&#8211;C2 (65&#8211;74) and had stabilized for 1 min. Following this, alfentanil was administrated (initial dose, 5 &#181;g/kg); if a positive reaction to the gastroscope placement was elicited, the dose was increased to a higher level in the next patient; otherwise, the dose was decreased to a lower level, with a dose gradient of 0.5 &#181;g/kg. Gastroscope insertion was started 90 s later, and the criteria for a positive reaction to gastroscope insertion included coughing, nausea, and/or motor reaction during or within 1 min of gastroscope insertion. The test was stopped if seven folds occurred during the study. The ED50 values with their 95% confidence intervals (CIs) of alfentanil in combination with propofol for the inhibition of gastroscopic placement were calculated.</p></sec><sec><title>Results</title><p id="Par9">Under the sedation conditions induced using alfentanil and propofol and detected using Narcotrend, the ED50 (95% CI) were 5.39 &#181;g/kg (4.76&#8211;6.47) in the youth group and 5.69 &#181;g/kg (4.67&#8211;6.31) in the elderly group, respectively.</p></sec><sec><title>Conclusions</title><p id="Par10">The ED50 of alfentanil combined with propofol for gastroscopy under Narcotrend monitoring were 5.39 &#181;g/kg in the youth group and 5.69 &#181;g/kg in the elderly group, respectively.</p></sec></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Alfentanil</kwd><kwd>Narcotrend</kwd><kwd>Propofol</kwd><kwd>Gastroscopy</kwd><kwd>Median effective dose</kwd></kwd-group><funding-group><award-group><funding-source><institution>Foshan Medical Research Project</institution></funding-source><award-id>20230250</award-id></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; BioMed Central Ltd., part of Springer Nature 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par11">Gastroscopy is primarily employed for diagnosing and treating upper gastrointestinal system ailments (Akahoshi et al. <xref ref-type="bibr" rid="CR1">2018</xref>; Veitch et al. <xref ref-type="bibr" rid="CR30">2021</xref>, <xref ref-type="bibr" rid="CR29">2015</xref>). It is an invasive procedure that can cause discomfort to the patients and have adverse effects on both their psychological and physiological well-being. As medical care has evolved to prioritize patient comfort, painless gastroscopy has gained widespread acceptance. Currently, propofol injection is the primary method used in clinical practice to alleviate the discomfort associated with gastroscopy (Stogiannou et al. <xref ref-type="bibr" rid="CR27">2018</xref>). However, the administration of pure propofol has raised concerns regarding the dosage and potential adverse reactions. To address these issues, the administration of propofol in combination with analgesic drugs during gastroscopy has gained traction. The American Society of Gastrointestinal Endoscopy guidelines for sedation anesthesia in gastrointestinal endoscopy recommend a regimen comprising opioids and propofol (ASGE Standards of Practice Committee&#160;et al.&#160;<xref ref-type="bibr" rid="CR2">2018</xref>). This approach is particularly significant for older patients, as their age-related physiological changes make them more sensitive to pain stimuli. While using propofol alone requires a substantial quantity of the drug to suppress the reflex responses of the patients, older patients often present with multiple underlying health conditions, diminishing their capacity to compensate for respiratory and circulatory disturbances (Liu et al. <xref ref-type="bibr" rid="CR15">2023</xref>; Sasaki et al. <xref ref-type="bibr" rid="CR22">2012</xref>). The use of analgesic drugs in conjunction with propofol effectively suppresses the reflex responses and allows for a reduction in the propofol dosage (Ye et al. <xref ref-type="bibr" rid="CR35">2017</xref>; Meng et al. <xref ref-type="bibr" rid="CR18">2016</xref>). This combination minimizes circulatory fluctuations and mitigates the discomfort associated with gastroscopy, ultimately decreasing perioperative risks.</p><p id="Par12">Opioid analgesics, such as those of the fentanyl family, are frequently employed to manage pain in the perioperative setting (Shanthanna et al. <xref ref-type="bibr" rid="CR24">2021</xref>; Kelly et al. <xref ref-type="bibr" rid="CR11">2023</xref>). Particularly, alfentanil stands out for its rapid onset of action (beginning within 30 s and peaking around 80 s). It has a relatively short duration of action of approximately 10&#8211;15 min and exhibits minimal respiratory depression (Hughes et al. <xref ref-type="bibr" rid="CR10">2023</xref>; Dong et al. <xref ref-type="bibr" rid="CR6">2023</xref>). These characteristics make it suitable for the analgesic requirements of minor outpatient surgical procedures. Initially, the practice of monitoring the depth of anesthesia was introduced to oversee the level of anesthesia during intubation to prevent patients from having intraoperative awareness. Therefore, the Narcotrend monitor (MonitorTechnik, Bad Bramstedt, Germany) was developed, which is an electroencephalogram monitor specifically designed to gauge the level of anesthesia depth. It has gained widespread acceptance in clinical practice due to its reliable performance (Kreuer and Wilhelm <xref ref-type="bibr" rid="CR12">2006</xref>; Puchner et al. <xref ref-type="bibr" rid="CR21">2020</xref>; Soehle et al. <xref ref-type="bibr" rid="CR26">2021</xref>). In clinical practice, the primary concern of anesthesiologists during gastroscopy is to ensure the safety and comfort of the patient. The objective is for the patient to undergo the examination in a relaxed state and awaken promptly afterward. Maintaining deep sedation is advantageous in this scenario, because in the case of commonly used sedative medications, deeper levels of anesthesia require higher dosages of the drug, resulting in pronounced suppression of the respiratory and circulatory functions (McGrath et al. <xref ref-type="bibr" rid="CR17">2021</xref>). Currently, determining the appropriate combination of alfentanil and propofol for gastroscopy relies largely on the expertise of anesthesiologists. Hence, we initiated this study to explore the optimal dosage of alfentanil in combination with propofol for gastroscopy, utilizing Narcotrend monitoring. Our primary objective was to enhance the precision of medication dosing for gastroscopy, thereby elevating patient satisfaction levels and diminishing the perioperative anesthesia-related risks.</p></sec><sec id="Sec2"><title>Methods</title><p id="Par13">This single-center, prospective clinical study was approved by the Ethics Committee of the Seventh Affiliated Hospital of Southern Medical University and was registered in the China Clinical Trial Registry on September 02, 2022 (ChiCTR2200063245). Written informed consent was obtained from all patients before starting the study.</p></sec><sec id="Sec3"><title>Patients</title><p id="Par14">This study included patients aged 18&#8211;80 years, with body mass index 18&#8211;28 kg/m<sup>2</sup>, and American Society of Anesthesiologists (ASA) Class I or II, who had undergone elective painless gastroscopy from October to December 2022. The exclusion criteria were a history of hypertension, hyperthyroidism, neurological, and psychiatric diseases, consumption of opioids or non-steroidal anti-inflammatory drugs 48 h before the procedure, participation in a clinical trial of other drugs in the last 4 weeks, allergy to the study drug propofol, and a history of opioid addiction.</p></sec><sec id="Sec4"><title>Anesthesia management</title><p id="Par15">Before the examination, the patient was subjected to routine fasting and administered 10 mL of dyclonine hydrochloride mucilage (1%) orally. After entering the examination room, the patient was placed in the left lateral position, the peripheral veins of the upper limbs were opened, and oxygen was administered by the nasal catheter at a rate of 3 L/min. The patient was routinely connected to a monitor to check the basic vital signs, such as blood pressure (blood pressure monitoring frequency was set at 5-min intervals, with additional measurements performed immediately upon clinical indication), heart rate (HR), oxygen saturation (SpO2), and respiratory rate. The Narcotrend anesthesia depth detector was connected, and propofol was injected intravenously using the target-controlled infusion pump. The starting dose was 2 &#181;g/mL, and the concentration was gradually increased with a dose gradient of 0.25 &#181;g/mL until the Narcotrend index was within the routine sedation stage of C1&#8211;C2 (65&#8211;74). Alfentanil was injected slowly with a starting dose of 5 &#181;g/kg, and the dose was determined according to whether there was a positive reaction during the operation, a positive reaction to gastroscope insertion included coughing, nausea, and/or motor reaction during or within 1 min of gastroscope insertion, conversely, the absence of such reaction was recorded as a negative response. The alfentanil dosage should be adjusted according to patient response: reduced following positive responses and increased by 0.5 &#181;g/kg after negative responses and gastroscopy was started after 60 s. During the operation, if the SpO2 was&#8201;&#8804;&#8201;93%, the inhaled oxygen flow was increased, and the airway was opened by holding the lower jaw. However, if the SpO2 was&#8201;&#8804;&#8201;80%, oxygen was supplied under pressure using a mask. If the mean arterial pressure (MAP) decreased by&#8201;&gt;&#8201;30% of the basal value, phenylephrine 50 &#181;g was administered. If the HR was&#8201;&#8804;&#8201;50 beats/min, atropine 0.5 mg was administered.</p></sec><sec id="Sec5"><title>Statistical analysis</title><p id="Par16">Data were analyzed using Statistical Product and Service Solutions, version 26.0. Normally distributed measures are expressed as means&#8201;&#177;&#8201;standard deviations. The <italic toggle="yes">x</italic><sup>2</sup> test or Fisher exact probability method was used to compare the count data between the groups. <italic toggle="yes">P</italic>&#8201;&lt;&#8201;0.05 was indicated to represent statistically significantly difference. Quantification of the 50% effective dose (ED50) was achieved through implementation of centered isotonic regression analysis within cir package (v2.5.1) within the R statistical computing environment (v4.5.1) (Oron et al. <xref ref-type="bibr" rid="CR20">2022</xref>). The Bootstrap ED50 difference method employs resampling techniques to compare median effective doses (ED50) between two groups.</p></sec><sec id="Sec6"><title>Results</title><p id="Par17">This study included 51 patients who underwent gastroscopy (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>), of which 26 patients belonged to the youth group (18&#8211;60 years) and 25 patients to the elderly group (61&#8211;80 years). Table <xref rid="Tab1" ref-type="table">1</xref> shows the demographic characteristics of the patients. The patient characteristics were substantially similar between the groups, with notable distinctions primarily in the mean age and ASA classification. The proportion of ASA II patients was notably higher in the elderly group than in the youth groups. Specifically, ASA class II patients comprised 15.3% of the youth group and 40% of the elderly group.<fig id="Fig1" position="float" orientation="portrait"><label>Fig.&#160;1</label><caption><p>Flow diagram of included participants</p></caption><graphic id="MO1" position="float" orientation="portrait" xlink:href="13741_2025_579_Fig1_HTML.jpg"/></fig><table-wrap id="Tab1" position="float" orientation="portrait"><label>Table&#160;1</label><caption><p>Demographic data</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristics</th><th align="left" colspan="1" rowspan="1">Youth (<italic toggle="yes">n</italic>&#8201;=&#8201;26)</th><th align="left" colspan="1" rowspan="1">Elderly (<italic toggle="yes">n</italic>&#8201;=&#8201;25)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Sex, male: female</td><td align="left" colspan="1" rowspan="1">12, 14</td><td align="left" colspan="1" rowspan="1">14, 11</td></tr><tr><td align="left" colspan="1" rowspan="1">Age (y)</td><td align="left" colspan="1" rowspan="1">36.9&#8201;&#177;&#8201;8.16</td><td align="left" colspan="1" rowspan="1">67.8&#8201;&#177;&#8201;4.05</td></tr><tr><td align="left" colspan="1" rowspan="1">BMI (kg/m<sup>2</sup>)</td><td align="left" colspan="1" rowspan="1">22.6&#8201;&#177;&#8201;3.23</td><td align="left" colspan="1" rowspan="1">21.3&#8201;&#177;&#8201;2.71</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>ASA &#8544; and &#8545;</p><p>Diabetes</p><p>Cardiovascular disease</p></td><td align="left" colspan="1" rowspan="1"><p>22, 4</p><p>1</p><p>0</p></td><td align="left" colspan="1" rowspan="1"><p>10, 15</p><p>5</p><p>2</p></td></tr></tbody></table><table-wrap-foot><p>Values are presented as mean&#8201;&#177;&#8201;SD or number (%). <italic toggle="yes">BMI</italic> body mass index, <italic toggle="yes">ASA</italic> &#8544;and &#8545;: American Society of Anesthesiologists physical status &#8544;and &#8545;</p></table-wrap-foot></table-wrap></p><p id="Par18">An assessment of the ED of alfentanil using a sequential method revealed that the ED50 of alfentanil combined with propofol for gastroscopy under Narcotrend monitoring were 5.39 &#181;g/kg (4.76&#8211;6.47) in the youth group and 5.69 &#181;g/kg (4.67&#8211;6.31) in the elderly group, respectively. Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref> display the DiXON top and bottom plots for each group. During the gastroscopy procedure, the Narcotrend index was consistently found to be in the range of 64 to 75. As shown in Table&#160;<xref rid="Tab2" ref-type="table">2</xref>, the average gastric endoscopy durations in the youth and elderly groups were 6.2&#8201;&#177;&#8201;2.1 min and 7.5&#8201;&#177;&#8201;1.8 min, respectively, with the latter showing slightly longer examination times than the former. However, this difference lacked statistical significance, probably due to the higher incidence of gastric diseases in the older population. The propofol dosages administered in the youth and elderly groups were 125&#8201;&#177;&#8201;12.3 mg and 103&#8201;&#177;&#8201;10.5 mg, respectively, without a statistically significant difference; however, the elderly group exhibited a lower propofol consumption rate per minute than the youth group. This suggests that older patients may be more sensitive to sedative medications than younger patients. The MAP and HR variations before anesthesia, at the start of surgery, and after recovery in the two groups are presented in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, and the variations were relatively stable, especially in the youth group. The awakening time in the youth and elderly groups were 3.2&#8201;&#177;&#8201;1.1 min and 4.1&#8201;&#177;&#8201;0.8 min, respectively. Variations in heart rate and mean arterial pressure were noted in both groups at different time intervals, as illustrated in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref><fig id="Fig2" position="float" orientation="portrait"><label>Fig.&#160;2</label><caption><p>Dixon up-and-down plots for two groups. The black dot &#8220;&#9679;&#8221; represents ineffective, and the white dot &#8220;&#9675;&#8221; represents effective</p></caption><graphic id="MO2" position="float" orientation="portrait" xlink:href="13741_2025_579_Fig2_HTML.jpg"/></fig><table-wrap id="Tab2" position="float" orientation="portrait"><label>Table&#160;2</label><caption><p>Information of surgery and medication</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Characteristics</th><th align="left" colspan="1" rowspan="1">Youth (<italic toggle="yes">n</italic>&#8201;=&#8201;26)</th><th align="left" colspan="1" rowspan="1">Elderly (<italic toggle="yes">n</italic>&#8201;=&#8201;25)</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">Propofol (mg)</td><td align="left" colspan="1" rowspan="1">125&#8201;&#177;&#8201;12.3</td><td char="." align="char" colspan="1" rowspan="1">103&#8201;&#177;&#8201;10.5</td></tr><tr><td align="left" colspan="1" rowspan="1">ST (surgery time, min)</td><td align="left" colspan="1" rowspan="1">6.2&#8201;&#177;&#8201;2.1</td><td char="." align="char" colspan="1" rowspan="1">7.5&#8201;&#177;&#8201;1.8</td></tr><tr><td align="left" colspan="1" rowspan="1"><p>AT (awakening time, min)</p><p>Time of staying in PACU (min)</p><p>Hypoxemia</p><p>Hypotension</p><p>Bradycardia</p></td><td align="left" colspan="1" rowspan="1"><p>3.2&#8201;&#177;&#8201;1.1</p><p>18.5&#8201;&#177;&#8201;4.8</p><p>1</p><p>2</p><p>0</p></td><td char="." align="char" colspan="1" rowspan="1"><p>4.1&#8201;&#177;&#8201;0.8</p><p>21&#8201;&#177;&#8201;5.1</p><p>1</p><p>3</p><p>1</p></td></tr></tbody></table></table-wrap><fig id="Fig3" position="float" orientation="portrait"><label>Figure3</label><caption><p>Heart rate(HR) and mean arterial pressure(MAP) changes were observed in the two groups at various time points: T1 (preoperative), T2 (after induction), T3 (at the beginning of surgery), and T4 (after the end of surgery)</p></caption><graphic id="MO3" position="float" orientation="portrait" xlink:href="13741_2025_579_Fig3_HTML.jpg"/></fig></p><p id="Par19">Throughout the examination process, eight instances of complications necessitating interventions were reported among the patients who underwent successful examinations. Specifically, five instances were observed in the elderly group, while the remaining three occurred in the youth group. These complications included two cases of hypoxemia, five of hypotension, and one of bradycardia. According the clinical management protocol, hypoxemic patients (SpO&#8322;&#8201;&lt;&#8201;93%) achieved sustained peripheral oxygen saturation maintenance (SpO&#8322;&#8201;&#8805;&#8201;93%) following increasing inhaled oxygen flow and mandibular advancement maneuver. For bradycardic presentations, pharmacological intervention with intravenous atropine (0.5 mg) successfully increased the heart rate to more than 60 bpm. Hemodynamic stabilization was accomplished in 4/5 hypotensive cases through single-dose phenylephrine administration (50 &#181;g IV bolus), with the remaining case requiring repeated dosing (cumulative 100 &#181;g) to achieve sustained normotension (MAP&#8201;&#8805;&#8201;65 mmHg).</p></sec><sec id="Sec7"><title>Discussion</title><p id="Par20">Propofol is a fast-acting, short-duration general anesthetic, widely used to induce anesthesia for various surgeries and examinations, intensive care unit sedation, and insomnia treatment (Lundstr&#246;m et al. <xref ref-type="bibr" rid="CR16">2010</xref>; Xu et al. <xref ref-type="bibr" rid="CR33">2011</xref>; Tang et al. <xref ref-type="bibr" rid="CR28">2022</xref>). Propofol takes approximately 30 s to take effect after the initial injection, has a quick first distribution phase lasting 2&#8211;4 min, and an elimination phase of 30&#8211;60 min. Hence, it is a frequently employed anesthetic in gastrointestinal endoscopic surgery. The depth of anesthesia is influenced by the dosage of sedative anesthetic agents; however, increased dosages of these sedatives correlate with heightened suppression of circulation and respiration. To mitigate potential complications, the depth of anesthesia is monitored to achieve a sedated and amnesic state in patients undergoing gastroscopy, thus reducing the risks associated with the procedure. To reduce the dosage of propofol administered and to attenuate the patient&#8217;s reflexes to gastroscopic stimuli, analgesics have been introduced in combination with the sedative agents used in gastroscopy (Zhou et al. <xref ref-type="bibr" rid="CR36">2021</xref>; LaPierre et al. <xref ref-type="bibr" rid="CR13">2012</xref>). Alfentanil, a short-acting opioid analgesic, takes effect immediately following intravenous administration, with a rapid initial distribution phase of 1 min and a slow secondary distribution phase lasting 14 min (Hughes et al. <xref ref-type="bibr" rid="CR10">2023</xref>; Scholz et al. <xref ref-type="bibr" rid="CR23">1996</xref>). The pharmacological characteristics of alfentanil and propofol make them suitable for anesthesia and sedation protocols in short, minor surgical procedures. The utilization of Narcotrend to monitor the anesthesia depth allows patients to undergo gastroscopy while in an amnesic state, representing a significant advancement in patient comfort. Thus, the application of alfentanil as an analgesic helps suppress the patient&#8217;s movement response, facilitating the completion of gastroscopy by the operator. The sequential method, as introduced by DiXON, is a straightforward, expeditious, and preliminary approach employed for the calculation of crucial pharmacological parameters, such as the median ED50. This method, known for its simplicity and rapidity, has found widespread application in the field of pharmacology, particularly in the assessment of drug potency (Dixon <xref ref-type="bibr" rid="CR5">1991</xref>; Niu et al. <xref ref-type="bibr" rid="CR19">2017</xref>; Coppens et al. <xref ref-type="bibr" rid="CR4">2017</xref>). In this study, the sequential method was employed to ascertain the ED50 of alfentanil for gastroscopy when combined with propofol under the guidance of Narcotrend monitoring.</p><p id="Par21">In the gastroscopy procedure, the most significant challenge arises during the insertion of the scope into the pharynx. This step can trigger various adverse reactions, including coughing, nausea, vomiting, resistance to the procedure, and even complications such as hemodynamic deterioration and esophageal rupture (Chen et al. <xref ref-type="bibr" rid="CR3">2022</xref>). To manage these stress-inducing responses effectively and minimize complications, it is imperative to administer adequate sedation and analgesia.</p><p id="Par22">Therefore, the key to successful gastroscopy lies in the induction of proper sedation and analgesia, which effectively mitigates the stress response and reduces the likelihood of complications. Propofol is a sedative with no intrinsic analgesic properties. In traditional gastroscopy procedures, the use of propofol alone typically involves the administration of high doses of sedatives to induce deep anesthesia and suppress somatic reactions in the patient. However, this approach can lead to pronounced circulatory and respiratory suppression, substantially increasing the risk of respiratory and circulatory complications. Therefore, the use of sedatives combined with analgesics in painless gastroscopy helps alleviate the adverse reactions caused by sedatives. Opioid analgesics are commonly used pain relievers in painless gastroscopy examinations, mainly including fentanyl, sufentanil, and remifentanil. Alfentanil effectively attenuates the intense stimulation experienced during the entry phase of the procedure and is associated with a markedly lower incidence of respiratory depression compared to the aforementioned opioid analgesics (Yang et al. <xref ref-type="bibr" rid="CR34">2023</xref>). This makes it a better choice for managing pain and discomfort during gastroscopy while minimizing the potential for respiratory complications.</p><p id="Par23">We aim to create an environment where patient comfort and safety take precedence in gastroscopy. In stark contrast to surgical procedures, the uniqueness of endoscopic examinations is that they do not require a specific depth of general anesthesia. This not only contributes to a more relaxed and stress-free experience for individuals but also eliminates potential complications associated with deep anesthesia. Good sedation combined with analgesic drugs to suppress pain responses can achieve patient comfort and reduce adverse reactions, thereby shortening the patient&#8217;s hospital stay. Previous studies have predominantly focused on determining effective doses of sedative-alfentanil combinations for endoscopic procedures to avoid oversedation (Shi et al. <xref ref-type="bibr" rid="CR25">2022</xref>; Wu et al. <xref ref-type="bibr" rid="CR32">2024</xref>), reporting effective doses values for sedative combined with commonly used dosages of analgesics. These studies, akin to those employing propofol as the sole agent, predominantly rely on sedative medications to mitigate procedural stimuli. However, this methodology is associated with notable risks, including excessive sedation, pronounced hemodynamic instability, and the potential occurrence of burst suppression patterns on electroencephalography (EEG). Consequently, our research objective is to minimize sedative usage by focusing on alleviating patient apprehension through analgesic agents targeting the suppression of stimuli from invasive procedures. Unlike traditional methods that define sedation depth using scales like the Modified Observer&#8217;s Assessment of Alertness/Sedation (MOAA/S) (Wang et al. <xref ref-type="bibr" rid="CR31">2024</xref>; Huang et al. <xref ref-type="bibr" rid="CR9">2025</xref>), employing anesthesia depth monitors provides an objective means to maintain patients at a consistent anesthetic depth. This study innovatively maintains standardized sedation depth while systematically investigating alfentanil&#8217;s effective dose, better aligning with clinical practice. Furthermore, diverging from Li et al.&#8217;s methodology which targeted the surgical anesthesia stage (50&#8211;65) (Li et al. <xref ref-type="bibr" rid="CR14">2021</xref>), our study specifically investigates deep sedation (65&#8211;74). Preliminary statistics demonstrate improved hemodynamic stability and faster recovery during procedures. Subsequent investigations will employ randomized controlled trials to comprehensively compare our novel dosing regimen with propofol-based anesthesia for gastroscopy, evaluating effectiveness, adverse event rates, and recovery time. This approach aligns our research with the concept of precise anesthesia.</p><p id="Par24">We found that the ED50 of alfentanil were slightly elevated in this study compared to the usual use. This discrepancy could be attributed to the intentional use of lower sedative doses in our study to maintain a lighter level of anesthesia and reduce complications related to sedative dosage. Although the demand for analgesic drugs is not lower in older patients than in younger patients (Falzone et al. <xref ref-type="bibr" rid="CR8">2013</xref>), there is a significant reduction in the demand for sedative drugs (Duan et al. <xref ref-type="bibr" rid="CR7">2023</xref>). Notably, the observed numerical trend of marginally higher ED50 values in elderly group (5.69 vs 5.39 &#956;g/kg), we propose this pattern may reflect age-related pharmacodynamic responses: Younger patients&#8217; greater propofol requirements to maintain equivalent anesthetic depth might concurrently suppress visceral nociceptive signaling during endoscopy through dose-dependent analgesic effects. Studies indicate that sedative drugs have more pronounced side effects in older patients than in younger patients because their compensatory abilities are weaker, making them more prone to circulatory and respiratory suppression. Therefore, the MAP of our patients remained relatively stable throughout the study. The analysis revealed no statistically significant difference in complication rates between the two patient cohorts. Additionally, the postoperative awakening time was considerably shorter than that of the conventional protocol, and the elderly group benefited more than the youth group. Hence, we have initiated a comprehensive study to compare the pros and cons of our dosage regimen and the conventional one.</p><p id="Par25">Our research has some limitations. First, we only recruited patients classified as ASA I&#8211;II for the trial. In clinical practice, the compensatory abilities of higher ASA classification patients are weaker; hence, personalized anesthesia may be more beneficial for them. Our improved drug regimen may offer greater benefits for this subgroup. Moreover, we did not include patients aged&#8201;&#8805;&#8201;80 years. Second, our patient selection only considered age, and the conclusions may be more convincing if sex distinctions were also considered.</p></sec><sec id="Sec8"><title>Conclusion</title><p id="Par26">The combination of alfentanil and propofol can be safely used for painless gastroscopy under Narcotrend monitoring. The ED50 of alfentanil combined with propofol for gastroscopy under Narcotrend monitoring were 5.69 &#181;g/kg (4.67&#8211;6.31) in the youth group and 5.39 &#181;g/kg(4.76&#8211;6.47) in the elderly group.</p></sec></body><back><fn-group><fn><p><bold>Publisher's Note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Lili Jiang and Zhe Peng contributed equally to this work.</p></fn></fn-group><ack><title>Acknowledgements</title><p>We thank Bullet Edits Limited for the linguistic editing and proofreading of the manuscript.</p></ack><notes notes-type="author-contribution"><title>Authors&#8217; contributions</title><p>Zaisheng Qin and Jinping Huang have given substantial contributions to the conception or the design of the manuscript. Material preparation, data collection, and analysis were performed by Lili Jiang, Zhe Peng, Yuhui Deng, Zebang Qin, and Jianxia Li. The first draft of the manuscript was written by Lili Jiang and all authors commented on previous versions of the manuscript. All authors read and approved the final manuscript.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>Foshan Medical Research Project NO.20230250.</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>No datasets were generated or analysed during the current study.</p></notes><notes><title>Declarations</title><notes id="FPar2"><title>Ethics approval and consent to participate</title><p id="Par27">The study was approved by the Ethics Committee of the Seventh Affiliated Hospital of Southern Medical University and was registered in the China Clinical Trial Registry on September 02, 2022 (ChiCTR2200063245).</p></notes><notes id="FPar3"><title>Consent for publication</title><p id="Par28">Not applicable. The study did not contain any individual person&#8217;s data in any form (including individual details, images, or videos).</p></notes><notes id="FPar4" notes-type="COI-statement"><title>Competing interests</title><p id="Par29">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Akahoshi</surname><given-names>K</given-names></name><name name-style="western"><surname>Oya</surname><given-names>M</given-names></name><name name-style="western"><surname>Koga</surname><given-names>T</given-names></name><name name-style="western"><surname>Shiratsuchi</surname><given-names>Y</given-names></name></person-group><article-title>Current clinical management of gastrointestinal stromal tumor</article-title><source>World J Gastroenterol</source><year>2018</year><volume>24</volume><fpage>2806</fpage><lpage>2817</lpage><pub-id pub-id-type="doi">10.3748/wjg.v24.i26.2806</pub-id><pub-id pub-id-type="pmid">30018476</pub-id><pub-id pub-id-type="pmcid">PMC6048423</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Akahoshi K, Oya M, Koga T, Shiratsuchi Y. Current clinical management of gastrointestinal stromal tumor. World J Gastroenterol. 2018;24:2806&#8211;17. 10.3748/wjg.v24.i26.2806.<pub-id pub-id-type="pmid">30018476</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3748/wjg.v24.i26.2806</pub-id><pub-id pub-id-type="pmcid">PMC6048423</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><mixed-citation publication-type="other">ASGE Standards of Practice Committee, Early DS, Lightdale JR, Vargo JJ, Acosta RD, Chandrasekhara V, et al. Guidelines for sedation and anesthesia in GI endoscopy. Gastrointest Endosc. 2018;87:327&#8211;37. 10.1016/j.gie.2017.07.018.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.gie.2017.07.018</pub-id><pub-id pub-id-type="pmid">29306520</pub-id></mixed-citation></ref><ref id="CR3"><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Chen</surname><given-names>DX</given-names></name><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Wu</surname><given-names>XP</given-names></name><name name-style="western"><surname>Niu</surname><given-names>W</given-names></name><name name-style="western"><surname>Ding</surname><given-names>L</given-names></name><name name-style="western"><surname>Zeng</surname><given-names>HL</given-names></name><etal/></person-group><article-title>Comparison of a nasal mask and traditional nasal cannula during intravenous anesthesia for gastroscopy procedures: a randomized controlled trial</article-title><source>Anesth Analg</source><year>2022</year><volume>134</volume><fpage>615</fpage><lpage>623</lpage><pub-id pub-id-type="doi">10.1213/ANE.0000000000005828</pub-id><pub-id pub-id-type="pmid">34878412</pub-id><pub-id pub-id-type="pmcid">PMC8826611</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Chen DX, Yang H, Wu XP, Niu W, Ding L, Zeng HL, et al. Comparison of a nasal mask and traditional nasal cannula during intravenous anesthesia for gastroscopy procedures: a randomized controlled trial. Anesth Analg. 2022;134:615&#8211;23. 10.1213/ANE.0000000000005828.<pub-id pub-id-type="pmid">34878412</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1213/ANE.0000000000005828</pub-id><pub-id pub-id-type="pmcid">PMC8826611</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Coppens</surname><given-names>M</given-names></name><name name-style="western"><surname>Anssens</surname><given-names>S</given-names></name><name name-style="western"><surname>Parashchanka</surname><given-names>A</given-names></name><name name-style="western"><surname>Roelens</surname><given-names>K</given-names></name><name name-style="western"><surname>Deschepper</surname><given-names>E</given-names></name><name name-style="western"><surname>De Hert</surname><given-names>S</given-names></name><etal/></person-group><article-title>Determination of the median effective dose (ED50) of spinal chloroprocaine in labour analgesia</article-title><source>Anaesthesia</source><year>2017</year><volume>72</volume><fpage>598</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.1111/anae.13808</pub-id><pub-id pub-id-type="pmid">28102539</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Coppens M, Anssens S, Parashchanka A, Roelens K, Deschepper E, De Hert S, et al. Determination of the median effective dose (ED50) of spinal chloroprocaine in labour analgesia. Anaesthesia. 2017;72:598&#8211;602. 10.1111/anae.13808.<pub-id pub-id-type="pmid">28102539</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/anae.13808</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dixon</surname><given-names>WJ</given-names></name></person-group><article-title>Staircase bioassay: the up-and-down method</article-title><source>Neurosci Biobehav Rev</source><year>1991</year><volume>15</volume><fpage>47</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.1016/s0149-7634(05)80090-9</pub-id><pub-id pub-id-type="pmid">2052197</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Dixon WJ. Staircase bioassay: the up-and-down method. Neurosci Biobehav Rev. 1991;15:47&#8211;50. 10.1016/s0149-7634(05)80090-9.<pub-id pub-id-type="pmid">2052197</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0149-7634(05)80090-9</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dong</surname><given-names>S-A</given-names></name><name name-style="western"><surname>Guo</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>S-S</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L-L</given-names></name><name name-style="western"><surname>Wu</surname><given-names>L-N</given-names></name><name name-style="western"><surname>Song</surname><given-names>K</given-names></name><etal/></person-group><article-title>A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures</article-title><source>J Clin Anesth</source><year>2023</year><volume>86</volume><fpage>111077</fpage><pub-id pub-id-type="doi">10.1016/j.jclinane.2023.111077</pub-id><pub-id pub-id-type="pmid">36764022</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Dong S-A, Guo Y, Liu S-S, Wu L-L, Wu L-N, Song K, et al. A randomized, controlled clinical trial comparing remimazolam to propofol when combined with alfentanil for sedation during ERCP procedures. J Clin Anesth. 2023;86: 111077. 10.1016/j.jclinane.2023.111077.<pub-id pub-id-type="pmid">36764022</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jclinane.2023.111077</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Duan</surname><given-names>J</given-names></name><name name-style="western"><surname>Ju</surname><given-names>X</given-names></name><name name-style="western"><surname>Wang</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>N</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name></person-group><article-title>Effects of remimazolam and propofol on emergence agitation in elderly patients undergoing hip replacement: a clinical, randomized, controlled study</article-title><source>Drug des Devel Ther</source><year>2023</year><volume>17</volume><fpage>2669</fpage><lpage>2678</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S419146</pub-id><pub-id pub-id-type="pmid">37680862</pub-id><pub-id pub-id-type="pmcid">PMC10480494</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Duan J, Ju X, Wang X, Liu N, Xu S, Wang S. Effects of remimazolam and propofol on emergence agitation in elderly patients undergoing hip replacement: a clinical, randomized, controlled study. Drug des Devel Ther. 2023;17:2669&#8211;78. 10.2147/DDDT.S419146.<pub-id pub-id-type="pmid">37680862</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DDDT.S419146</pub-id><pub-id pub-id-type="pmcid">PMC10480494</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Falzone</surname><given-names>E</given-names></name><name name-style="western"><surname>Hoffmann</surname><given-names>C</given-names></name><name name-style="western"><surname>Keita</surname><given-names>H</given-names></name></person-group><article-title>Postoperative analgesia in elderly patients</article-title><source>Drugs Aging</source><year>2013</year><volume>30</volume><fpage>81</fpage><lpage>90</lpage><pub-id pub-id-type="doi">10.1007/s40266-012-0047-7</pub-id><pub-id pub-id-type="pmid">23288604</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Falzone E, Hoffmann C, Keita H. Postoperative analgesia in elderly patients. Drugs Aging. 2013;30:81&#8211;90. 10.1007/s40266-012-0047-7.<pub-id pub-id-type="pmid">23288604</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s40266-012-0047-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>X-D</given-names></name><name name-style="western"><surname>Xu</surname><given-names>L</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>C-H</given-names></name><name name-style="western"><surname>Chen</surname><given-names>M-M</given-names></name><name name-style="western"><surname>Shou</surname><given-names>H-Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>Z-F</given-names></name></person-group><article-title>Effect of fentanyl on remimazolam-induced sedation in female patients undergoing hysteroscopic surgery: a randomized controlled trial</article-title><source>Drug Des Devel Ther</source><year>2025</year><volume>19</volume><fpage>1393</fpage><lpage>401</lpage><pub-id pub-id-type="doi">10.2147/DDDT.S504189</pub-id><pub-id pub-id-type="pmid">40034404</pub-id><pub-id pub-id-type="pmcid">PMC11874992</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Huang X-D, Xu L, Zheng C-H, Chen M-M, Shou H-Y, Zhou Z-F. Effect of fentanyl on remimazolam-induced sedation in female patients undergoing hysteroscopic surgery: a randomized controlled trial. Drug Des Devel Ther. 2025;19:1393&#8211;401. 10.2147/DDDT.S504189.<pub-id pub-id-type="pmid">40034404</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2147/DDDT.S504189</pub-id><pub-id pub-id-type="pmcid">PMC11874992</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hughes</surname><given-names>LM</given-names></name><name name-style="western"><surname>Irwin</surname><given-names>MG</given-names></name><name name-style="western"><surname>Nestor</surname><given-names>CC</given-names></name></person-group><article-title>Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review</article-title><source>Anaesthesia</source><year>2023</year><volume>78</volume><fpage>620</fpage><lpage>625</lpage><pub-id pub-id-type="doi">10.1111/anae.15952</pub-id><pub-id pub-id-type="pmid">36562193</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Hughes LM, Irwin MG, Nestor CC. Alternatives to remifentanil for the analgesic component of total intravenous anaesthesia: a narrative review. Anaesthesia. 2023;78:620&#8211;5. 10.1111/anae.15952.<pub-id pub-id-type="pmid">36562193</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/anae.15952</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><citation-alternatives><element-citation id="ec-CR11" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kelly</surname><given-names>E</given-names></name><name name-style="western"><surname>Sutcliffe</surname><given-names>K</given-names></name><name name-style="western"><surname>Cavallo</surname><given-names>D</given-names></name><name name-style="western"><surname>Ramos-Gonzalez</surname><given-names>N</given-names></name><name name-style="western"><surname>Alhosan</surname><given-names>N</given-names></name><name name-style="western"><surname>Henderson</surname><given-names>G</given-names></name></person-group><article-title>The anomalous pharmacology of fentanyl</article-title><source>Br J Pharmacol</source><year>2023</year><volume>180</volume><fpage>797</fpage><lpage>812</lpage><pub-id pub-id-type="doi">10.1111/bph.15573</pub-id><pub-id pub-id-type="pmid">34030211</pub-id></element-citation><mixed-citation id="mc-CR11" publication-type="journal">Kelly E, Sutcliffe K, Cavallo D, Ramos-Gonzalez N, Alhosan N, Henderson G. The anomalous pharmacology of fentanyl. Br J Pharmacol. 2023;180:797&#8211;812. 10.1111/bph.15573.<pub-id pub-id-type="pmid">34030211</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/bph.15573</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR12"><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kreuer</surname><given-names>S</given-names></name><name name-style="western"><surname>Wilhelm</surname><given-names>W</given-names></name></person-group><article-title>The narcotrend monitor</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2006</year><volume>20</volume><fpage>111</fpage><lpage>119</lpage><pub-id pub-id-type="doi">10.1016/j.bpa.2005.08.010</pub-id><pub-id pub-id-type="pmid">16634418</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Kreuer S, Wilhelm W. The narcotrend monitor. Best Pract Res Clin Anaesthesiol. 2006;20:111&#8211;9. 10.1016/j.bpa.2005.08.010.<pub-id pub-id-type="pmid">16634418</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bpa.2005.08.010</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>LaPierre</surname><given-names>CD</given-names></name><name name-style="western"><surname>Johnson</surname><given-names>KB</given-names></name><name name-style="western"><surname>Randall</surname><given-names>BR</given-names></name><name name-style="western"><surname>Egan</surname><given-names>TD</given-names></name></person-group><article-title>A simulation study of common propofol and propofol-opioid dosing regimens for upper endoscopy: implications on the time course of recovery</article-title><source>Anesthesiology</source><year>2012</year><volume>117</volume><fpage>252</fpage><lpage>262</lpage><pub-id pub-id-type="doi">10.1097/ALN.0b013e31825fb1b2</pub-id><pub-id pub-id-type="pmid">22728781</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">LaPierre CD, Johnson KB, Randall BR, Egan TD. A simulation study of common propofol and propofol-opioid dosing regimens for upper endoscopy: implications on the time course of recovery. Anesthesiology. 2012;117:252&#8211;62. 10.1097/ALN.0b013e31825fb1b2.<pub-id pub-id-type="pmid">22728781</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0b013e31825fb1b2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Chen</surname><given-names>X</given-names></name><name name-style="western"><surname>Huang</surname><given-names>T</given-names></name><name name-style="western"><surname>Li</surname><given-names>N</given-names></name></person-group><article-title>Effective doses of nalbuphine combined with propofol for painless gastroscopy in adults: a randomized controlled trial</article-title><source>Front Pharmacol</source><year>2021</year><volume>12</volume><fpage>673550</fpage><pub-id pub-id-type="doi">10.3389/fphar.2021.673550</pub-id><pub-id pub-id-type="pmid">34924999</pub-id><pub-id pub-id-type="pmcid">PMC8672217</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Li S, Wang Y, Chen X, Huang T, Li N. Effective doses of nalbuphine combined with propofol for painless gastroscopy in adults: a randomized controlled trial. Front Pharmacol. 2021;12: 673550. 10.3389/fphar.2021.673550.<pub-id pub-id-type="pmid">34924999</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fphar.2021.673550</pub-id><pub-id pub-id-type="pmcid">PMC8672217</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liu</surname><given-names>X</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>Q</given-names></name><name name-style="western"><surname>Zhuang</surname><given-names>S</given-names></name></person-group><article-title>Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial</article-title><source>Front Med</source><year>2023</year><volume>10</volume><fpage>1184709</fpage><pub-id pub-id-type="doi">10.3389/fmed.2023.1184709</pub-id><pub-id pub-id-type="pmcid">PMC10442552</pub-id><pub-id pub-id-type="pmid">37614948</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Liu X, Xiao Q, Zhuang S. Comparison of propofol-esketamine versus propofol for anesthesia in gastroscopy: a double-blind, randomized controlled clinical trial. Front Med. 2023;10:1184709. 10.3389/fmed.2023.1184709.<pub-id pub-id-type="doi" assigning-authority="pmc">10.3389/fmed.2023.1184709</pub-id><pub-id pub-id-type="pmcid">PMC10442552</pub-id><pub-id pub-id-type="pmid">37614948</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lundstr&#246;m</surname><given-names>S</given-names></name><name name-style="western"><surname>Twycross</surname><given-names>R</given-names></name><name name-style="western"><surname>Mihalyo</surname><given-names>M</given-names></name><name name-style="western"><surname>Wilcock</surname><given-names>A</given-names></name></person-group><article-title>Propofol</article-title><source>J Pain Symptom Manage</source><year>2010</year><volume>40</volume><fpage>466</fpage><lpage>470</lpage><pub-id pub-id-type="doi">10.1016/j.jpainsymman.2010.07.001</pub-id><pub-id pub-id-type="pmid">20816571</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Lundstr&#246;m S, Twycross R, Mihalyo M, Wilcock A. Propofol. J Pain Symptom Manage. 2010;40:466&#8211;70. 10.1016/j.jpainsymman.2010.07.001.<pub-id pub-id-type="pmid">20816571</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpainsymman.2010.07.001</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>McGrath</surname><given-names>SP</given-names></name><name name-style="western"><surname>McGovern</surname><given-names>KM</given-names></name><name name-style="western"><surname>Perreard</surname><given-names>IM</given-names></name><name name-style="western"><surname>Huang</surname><given-names>V</given-names></name><name name-style="western"><surname>Moss</surname><given-names>LB</given-names></name><name name-style="western"><surname>Blike</surname><given-names>GT</given-names></name></person-group><article-title>Inpatient respiratory arrest associated with sedative and analgesic medications: impact of continuous monitoring on patient mortality and severe morbidity</article-title><source>J Patient Saf</source><year>2021</year><volume>17</volume><fpage>557</fpage><lpage>561</lpage><pub-id pub-id-type="doi">10.1097/PTS.0000000000000696</pub-id><pub-id pub-id-type="pmid">32175965</pub-id><pub-id pub-id-type="pmcid">PMC8612899</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">McGrath SP, McGovern KM, Perreard IM, Huang V, Moss LB, Blike GT. Inpatient respiratory arrest associated with sedative and analgesic medications: impact of continuous monitoring on patient mortality and severe morbidity. J Patient Saf. 2021;17:557&#8211;61. 10.1097/PTS.0000000000000696.<pub-id pub-id-type="pmid">32175965</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/PTS.0000000000000696</pub-id><pub-id pub-id-type="pmcid">PMC8612899</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Meng</surname><given-names>Q-T</given-names></name><name name-style="western"><surname>Cao</surname><given-names>C</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H-M</given-names></name><name name-style="western"><surname>Xia</surname><given-names>Z-Y</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Tang</surname><given-names>L-H</given-names></name><etal/></person-group><article-title>Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: a double-blind randomized clinical study</article-title><source>Exp Ther Med</source><year>2016</year><volume>12</volume><fpage>1515</fpage><lpage>1524</lpage><pub-id pub-id-type="doi">10.3892/etm.2016.3475</pub-id><pub-id pub-id-type="pmid">27602075</pub-id><pub-id pub-id-type="pmcid">PMC4998221</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Meng Q-T, Cao C, Liu H-M, Xia Z-Y, Li W, Tang L-H, et al. Safety and efficacy of etomidate and propofol anesthesia in elderly patients undergoing gastroscopy: a double-blind randomized clinical study. Exp Ther Med. 2016;12:1515&#8211;24. 10.3892/etm.2016.3475.<pub-id pub-id-type="pmid">27602075</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.3892/etm.2016.3475</pub-id><pub-id pub-id-type="pmcid">PMC4998221</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><citation-alternatives><element-citation id="ec-CR19" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Niu</surname><given-names>B</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>JY</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Zhou</surname><given-names>BY</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Cao</surname><given-names>F</given-names></name><etal/></person-group><article-title>Sevoflurane-induced isoelectric EEG and burst suppression: differential and antagonistic effect of added nitrous oxide</article-title><source>Anaesthesia</source><year>2017</year><volume>72</volume><fpage>570</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1111/anae.13843</pub-id><pub-id pub-id-type="pmid">28272748</pub-id><pub-id pub-id-type="pmcid">PMC5413860</pub-id></element-citation><mixed-citation id="mc-CR19" publication-type="journal">Niu B, Xiao JY, Fang Y, Zhou BY, Li J, Cao F, et al. Sevoflurane-induced isoelectric EEG and burst suppression: differential and antagonistic effect of added nitrous oxide. Anaesthesia. 2017;72:570&#8211;9. 10.1111/anae.13843.<pub-id pub-id-type="pmid">28272748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1111/anae.13843</pub-id><pub-id pub-id-type="pmcid">PMC5413860</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR20"><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Oron</surname><given-names>AP</given-names></name><name name-style="western"><surname>Souter</surname><given-names>MJ</given-names></name><name name-style="western"><surname>Flournoy</surname><given-names>N</given-names></name></person-group><article-title>Understanding research methods: up-and-down designs for dose-finding</article-title><source>Anesthesiology</source><year>2022</year><volume>137</volume><fpage>137</fpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000004282</pub-id><pub-id pub-id-type="pmid">35819863</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Oron AP, Souter MJ, Flournoy N. Understanding research methods: up-and-down designs for dose-finding. Anesthesiology. 2022;137:137. 10.1097/ALN.0000000000004282.<pub-id pub-id-type="pmid">35819863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0000000000004282</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Puchner</surname><given-names>WF</given-names></name><name name-style="western"><surname>D&#252;nser</surname><given-names>MW</given-names></name><name name-style="western"><surname>Paulus</surname><given-names>P</given-names></name><name name-style="western"><surname>Neuner</surname><given-names>MP</given-names></name><name name-style="western"><surname>Mayer</surname><given-names>CL</given-names></name><name name-style="western"><surname>Pomberger</surname><given-names>IM</given-names></name><etal/></person-group><article-title>A comparative study on adequate anesthesia depth: clinical judgement and the narcotrend&#174; measurement</article-title><source>Canadian Journal of Anesthesia/Journal canadien d'anesth&#233;sie</source><year>2020</year><volume>67</volume><fpage>664</fpage><lpage>73</lpage><pub-id pub-id-type="doi">10.1007/s12630-020-01602-x</pub-id><pub-id pub-id-type="pmid">32128723</pub-id><pub-id pub-id-type="pmcid">PMC7214482</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Puchner WF, D&#252;nser MW, Paulus P, Neuner MP, Mayer CL, Pomberger IM, et al. A comparative study on adequate anesthesia depth: clinical judgement and the narcotrend&#174; measurement. Canadian Journal of Anesthesia/Journal canadien d&#8217;anesth&#233;sie. 2020;67:664&#8211;73. 10.1007/s12630-020-01602-x.<pub-id pub-id-type="pmid">32128723</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12630-020-01602-x</pub-id><pub-id pub-id-type="pmcid">PMC7214482</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sasaki</surname><given-names>T</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>S</given-names></name><name name-style="western"><surname>Azuma</surname><given-names>M</given-names></name><name name-style="western"><surname>Sato</surname><given-names>A</given-names></name><name name-style="western"><surname>Naruke</surname><given-names>A</given-names></name><name name-style="western"><surname>Ishido</surname><given-names>K</given-names></name><etal/></person-group><article-title>Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial</article-title><source>Endoscopy</source><year>2012</year><volume>44</volume><fpage>584</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1055/s-0032-1306776</pub-id><pub-id pub-id-type="pmid">22638779</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Sasaki T, Tanabe S, Azuma M, Sato A, Naruke A, Ishido K, et al. Propofol sedation with bispectral index monitoring is useful for endoscopic submucosal dissection: a randomized prospective phase II clinical trial. Endoscopy. 2012;44:584&#8211;9. 10.1055/s-0032-1306776.<pub-id pub-id-type="pmid">22638779</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1055/s-0032-1306776</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scholz</surname><given-names>J</given-names></name><name name-style="western"><surname>Steinfath</surname><given-names>M</given-names></name><name name-style="western"><surname>Schulz</surname><given-names>M</given-names></name></person-group><article-title>Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update</article-title><source>Clin Pharmacokinet</source><year>1996</year><volume>31</volume><fpage>275</fpage><lpage>292</lpage><pub-id pub-id-type="doi">10.2165/00003088-199631040-00004</pub-id><pub-id pub-id-type="pmid">8896944</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Scholz J, Steinfath M, Schulz M. Clinical pharmacokinetics of alfentanil, fentanyl and sufentanil. An update. Clin Pharmacokinet. 1996;31:275&#8211;92. 10.2165/00003088-199631040-00004.<pub-id pub-id-type="pmid">8896944</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.2165/00003088-199631040-00004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shanthanna</surname><given-names>H</given-names></name><name name-style="western"><surname>Ladha</surname><given-names>KS</given-names></name><name name-style="western"><surname>Kehlet</surname><given-names>H</given-names></name><name name-style="western"><surname>Joshi</surname><given-names>GP</given-names></name></person-group><article-title>Perioperative opioid administration</article-title><source>Anesthesiology</source><year>2021</year><volume>134</volume><fpage>645</fpage><lpage>659</lpage><pub-id pub-id-type="doi">10.1097/ALN.0000000000003572</pub-id><pub-id pub-id-type="pmid">32991672</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Shanthanna H, Ladha KS, Kehlet H, Joshi GP. Perioperative opioid administration. Anesthesiology. 2021;134:645&#8211;59. 10.1097/ALN.0000000000003572.<pub-id pub-id-type="pmid">32991672</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/ALN.0000000000003572</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>W</given-names></name><name name-style="western"><surname>Cheng</surname><given-names>Y</given-names></name><name name-style="western"><surname>He</surname><given-names>H</given-names></name><name name-style="western"><surname>Fang</surname><given-names>Q</given-names></name><name name-style="western"><surname>Hu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Efficacy and safety of the remimazolam-alfentanil combination for sedation during gastroscopy: a randomized, double-blind, single-center controlled trial</article-title><source>Clin Ther</source><year>2022</year><volume>44</volume><fpage>1506</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.1016/j.clinthera.2022.09.014</pub-id><pub-id pub-id-type="pmid">36763995</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Shi W, Cheng Y, He H, Fang Q, Hu Y, Xu X, et al. Efficacy and safety of the remimazolam-alfentanil combination for sedation during gastroscopy: a randomized, double-blind, single-center controlled trial. Clin Ther. 2022;44:1506&#8211;18. 10.1016/j.clinthera.2022.09.014.<pub-id pub-id-type="pmid">36763995</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clinthera.2022.09.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><citation-alternatives><element-citation id="ec-CR26" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Soehle</surname><given-names>M</given-names></name><name name-style="western"><surname>Bochem</surname><given-names>J</given-names></name><name name-style="western"><surname>Kayser</surname><given-names>S</given-names></name><name name-style="western"><surname>Weyerh&#228;user</surname><given-names>J</given-names></name><name name-style="western"><surname>Valero</surname><given-names>R</given-names></name></person-group><article-title>Challenges and pitfalls in anesthesia for electroconvulsive therapy</article-title><source>Best Pract Res Clin Anaesthesiol</source><year>2021</year><volume>35</volume><fpage>181</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.bpa.2020.12.012</pub-id><pub-id pub-id-type="pmid">34030803</pub-id></element-citation><mixed-citation id="mc-CR26" publication-type="journal">Soehle M, Bochem J, Kayser S, Weyerh&#228;user J, Valero R. Challenges and pitfalls in anesthesia for electroconvulsive therapy. Best Pract Res Clin Anaesthesiol. 2021;35:181&#8211;9. 10.1016/j.bpa.2020.12.012.<pub-id pub-id-type="pmid">34030803</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bpa.2020.12.012</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR27"><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stogiannou</surname><given-names>D</given-names></name><name name-style="western"><surname>Protopapas</surname><given-names>A</given-names></name><name name-style="western"><surname>Protopapas</surname><given-names>A</given-names></name><name name-style="western"><surname>Tziomalos</surname><given-names>K</given-names></name></person-group><article-title>Is propofol the optimal sedative in gastrointestinal endoscopy?</article-title><source>Acta Gastro-Enterol Belg</source><year>2018</year><volume>81</volume><fpage>520</fpage><lpage>524</lpage><pub-id pub-id-type="pmid">30645922</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Stogiannou D, Protopapas A, Protopapas A, Tziomalos K. Is propofol the optimal sedative in gastrointestinal endoscopy? Acta Gastro-Enterol Belg. 2018;81:520&#8211;4.<pub-id pub-id-type="pmid">30645922</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Yang</surname><given-names>X</given-names></name><name name-style="western"><surname>Yu</surname><given-names>Y</given-names></name><name name-style="western"><surname>Shu</surname><given-names>H</given-names></name><name name-style="western"><surname>Yuan</surname><given-names>Y</given-names></name><name name-style="western"><surname>Liu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study</article-title><source>Crit Care</source><year>2022</year><volume>26</volume><fpage>279</fpage><pub-id pub-id-type="doi">10.1186/s13054-022-04168-w</pub-id><pub-id pub-id-type="pmid">36114552</pub-id><pub-id pub-id-type="pmcid">PMC9482181</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Tang Y, Yang X, Yu Y, Shu H, Yuan Y, Liu H, et al. Remimazolam besylate versus propofol for long-term sedation during invasive mechanical ventilation: a pilot study. Crit Care. 2022;26: 279. 10.1186/s13054-022-04168-w.<pub-id pub-id-type="pmid">36114552</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13054-022-04168-w</pub-id><pub-id pub-id-type="pmcid">PMC9482181</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><citation-alternatives><element-citation id="ec-CR29" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veitch</surname><given-names>AM</given-names></name><name name-style="western"><surname>Uedo</surname><given-names>N</given-names></name><name name-style="western"><surname>Yao</surname><given-names>K</given-names></name><name name-style="western"><surname>East</surname><given-names>JE</given-names></name></person-group><article-title>Optimizing early upper gastrointestinal cancer detection at endoscopy</article-title><source>Nat Rev Gastroenterol Hepatol</source><year>2015</year><volume>12</volume><fpage>660</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/nrgastro.2015.128</pub-id><pub-id pub-id-type="pmid">26260369</pub-id></element-citation><mixed-citation id="mc-CR29" publication-type="journal">Veitch AM, Uedo N, Yao K, East JE. Optimizing early upper gastrointestinal cancer detection at endoscopy. Nat Rev Gastroenterol Hepatol. 2015;12:660&#8211;7. 10.1038/nrgastro.2015.128.<pub-id pub-id-type="pmid">26260369</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrgastro.2015.128</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR30"><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Veitch</surname><given-names>AM</given-names></name><name name-style="western"><surname>Radaelli</surname><given-names>F</given-names></name><name name-style="western"><surname>Alikhan</surname><given-names>R</given-names></name><name name-style="western"><surname>Dumonceau</surname><given-names>JM</given-names></name><name name-style="western"><surname>Eaton</surname><given-names>D</given-names></name><name name-style="western"><surname>Jerrome</surname><given-names>J</given-names></name><etal/></person-group><article-title>Endoscopy in patients on antiplatelet or anticoagulant therapy: British society of gastroenterology (BSG) and european society of gastrointestinal endoscopy (ESGE) guideline update</article-title><source>Gut</source><year>2021</year><volume>70</volume><fpage>1611</fpage><lpage>1628</lpage><pub-id pub-id-type="doi">10.1136/gutjnl-2021-325184</pub-id><pub-id pub-id-type="pmid">34362780</pub-id><pub-id pub-id-type="pmcid">PMC8355884</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Veitch AM, Radaelli F, Alikhan R, Dumonceau JM, Eaton D, Jerrome J, et al. Endoscopy in patients on antiplatelet or anticoagulant therapy: British society of gastroenterology (BSG) and european society of gastrointestinal endoscopy (ESGE) guideline update. Gut. 2021;70:1611&#8211;28. 10.1136/gutjnl-2021-325184.<pub-id pub-id-type="pmid">34362780</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2021-325184</pub-id><pub-id pub-id-type="pmcid">PMC8355884</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>P</given-names></name><name name-style="western"><surname>Xue</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Gao</surname><given-names>K</given-names></name><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name></person-group><article-title>Determination of ED50 and ED95 of remimazolam besylate combined with alfentanil for adult gastroscopy: a prospective dose-finding study</article-title><source>Brazilian Journal of Anesthesiology (English Edition)</source><year>2024</year><volume>74</volume><fpage>844518</fpage><pub-id pub-id-type="doi">10.1016/j.bjane.2024.844518</pub-id><pub-id pub-id-type="pmcid">PMC11167255</pub-id><pub-id pub-id-type="pmid">38789004</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Wang P, Xue S, Zhang L, Gao K, Wang Y. Determination of ED50 and ED95 of remimazolam besylate combined with alfentanil for adult gastroscopy: a prospective dose-finding study. Brazilian Journal of Anesthesiology (English Edition). 2024;74: 844518. 10.1016/j.bjane.2024.844518.<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bjane.2024.844518</pub-id><pub-id pub-id-type="pmcid">PMC11167255</pub-id><pub-id pub-id-type="pmid">38789004</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>X</given-names></name><name name-style="western"><surname>Liao</surname><given-names>M</given-names></name><name name-style="western"><surname>Lin</surname><given-names>X</given-names></name><name name-style="western"><surname>Hu</surname><given-names>J</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>T</given-names></name><name name-style="western"><surname>Sun</surname><given-names>H</given-names></name></person-group><article-title>Effective doses of ciprofol combined with alfentanil in inhibiting responses to gastroscope insertion, a prospective, single-arm, single-center study</article-title><source>BMC Anesthesiol</source><year>2024</year><volume>24</volume><fpage>2</fpage><pub-id pub-id-type="doi">10.1186/s12871-023-02387-4</pub-id><pub-id pub-id-type="pmid">38166724</pub-id><pub-id pub-id-type="pmcid">PMC10759617</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Wu X, Liao M, Lin X, Hu J, Zhao T, Sun H. Effective doses of ciprofol combined with alfentanil in inhibiting responses to gastroscope insertion, a prospective, single-arm, single-center study. BMC Anesthesiol. 2024;24:2. 10.1186/s12871-023-02387-4.<pub-id pub-id-type="pmid">38166724</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12871-023-02387-4</pub-id><pub-id pub-id-type="pmcid">PMC10759617</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Jiang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>W</given-names></name><name name-style="western"><surname>Gao</surname><given-names>D</given-names></name><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><name name-style="western"><surname>Liu</surname><given-names>J</given-names></name></person-group><article-title>Propofol-induced sleep: efficacy and safety in patients with refractory chronic primary insomnia</article-title><source>Cell Biochem Biophys</source><year>2011</year><volume>60</volume><fpage>161</fpage><lpage>166</lpage><pub-id pub-id-type="doi">10.1007/s12013-010-9135-7</pub-id><pub-id pub-id-type="pmid">21107748</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">Xu Z, Jiang X, Li W, Gao D, Li X, Liu J. Propofol-induced sleep: efficacy and safety in patients with refractory chronic primary insomnia. Cell Biochem Biophys. 2011;60:161&#8211;6. 10.1007/s12013-010-9135-7.<pub-id pub-id-type="pmid">21107748</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s12013-010-9135-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>H</given-names></name><name name-style="western"><surname>Shi</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>J</given-names></name><name name-style="western"><surname>Yang</surname><given-names>L</given-names></name></person-group><article-title>Efficacy and safety of alfentanil plus propofol versus propofol only in painless gastrointestinal endoscopy: a meta-analysis</article-title><source>Medicine (Baltimore)</source><year>2023</year><volume>102</volume><fpage>e34745</fpage><pub-id pub-id-type="doi">10.1097/MD.0000000000034745</pub-id><pub-id pub-id-type="pmid">37565872</pub-id><pub-id pub-id-type="pmcid">PMC10419350</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Yang H, Shi X, Li J, Yang L. Efficacy and safety of alfentanil plus propofol versus propofol only in painless gastrointestinal endoscopy: a meta-analysis. Medicine (Baltimore). 2023;102: e34745. 10.1097/MD.0000000000034745.<pub-id pub-id-type="pmid">37565872</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/MD.0000000000034745</pub-id><pub-id pub-id-type="pmcid">PMC10419350</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ye</surname><given-names>L</given-names></name><name name-style="western"><surname>Xiao</surname><given-names>X</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>L</given-names></name></person-group><article-title>The comparison of etomidate and propofol anesthesia in patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis</article-title><source>Surg Laparosc Endosc Percutan Tech</source><year>2017</year><volume>27</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1097/SLE.0000000000000373</pub-id><pub-id pub-id-type="pmid">28079763</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Ye L, Xiao X, Zhu L. The comparison of etomidate and propofol anesthesia in patients undergoing gastrointestinal endoscopy: a systematic review and meta-analysis. Surg Laparosc Endosc Percutan Tech. 2017;27:1&#8211;7. 10.1097/SLE.0000000000000373.<pub-id pub-id-type="pmid">28079763</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/SLE.0000000000000373</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>S</given-names></name><name name-style="western"><surname>Zhu</surname><given-names>Z</given-names></name><name name-style="western"><surname>Dai</surname><given-names>W</given-names></name><name name-style="western"><surname>Qi</surname><given-names>S</given-names></name><name name-style="western"><surname>Tian</surname><given-names>W</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>National survey on sedation for gastrointestinal endoscopy in 2758 Chinese hospitals</article-title><source>Br J Anaesth</source><year>2021</year><volume>127</volume><fpage>56</fpage><lpage>64</lpage><pub-id pub-id-type="doi">10.1016/j.bja.2021.01.028</pub-id><pub-id pub-id-type="pmid">33685636</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Zhou S, Zhu Z, Dai W, Qi S, Tian W, Zhang Y, et al. National survey on sedation for gastrointestinal endoscopy in 2758 Chinese hospitals. Br J Anaesth. 2021;127:56&#8211;64. 10.1016/j.bja.2021.01.028.<pub-id pub-id-type="pmid">33685636</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.bja.2021.01.028</pub-id></mixed-citation></citation-alternatives></ref></ref-list></back></article>
        
    </metadata>
</record>
    </GetRecord>

</OAI-PMH>